Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Inventory of $64000.0 for Q4 2016, down 65.78% year-over-year from $187000.0 in Q1 2016, and up 3.23% quarter-over-quarter from $62000.0 in Q3 2016.
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Inventory history runs 4 years deep, the most recent figure standing at $64000.0 for Q4 2016.
- In Q4 2016, Inventory fell 65.78% year-over-year to $64000.0; the TTM figure through Dec 2016 stood at $64000.0 (down 65.78% YoY), while the FY2016 annual figure was $64000.0, down 65.78% from the prior year.
- Inventory for Q4 2016 stood at $64000.0, up from $62000.0 in the prior quarter.
- The five-year high for Inventory was $536000.0 in Q2 2015, with the low at $62000.0 in Q3 2016.
- The 4-year median for Inventory is $222532.0 (2014), against an average of $248850.3.
- The sharpest annual moves came in 2015 and 2016: Inventory surged 177.52% in 2015, then slumped 82.97% in 2016.
- Viridian Therapeutics, Inc.\DE's Inventory stood at $357000.0 in 2013, then slumped by 49.86% to $179000.0 in 2014, then advanced by 4.47% to $187000.0 in 2015, then sank by 65.78% to $64000.0 in 2016.
- Business Quant data shows VRDN's Inventory at $64000.0 in Q4 2016, $62000.0 in Q3 2016, and $213000.0 in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 64,000.00 |
| Sep 30, 2016 | 62,000.00 |
| Jun 30, 2016 | 213,000.00 |
| Mar 31, 2016 | 269,000.00 |
| Dec 31, 2015 | 187,000.00 |
| Sep 30, 2015 | 364,000.00 |
| Jun 30, 2015 | 536,000.00 |
| Mar 31, 2015 | 330,000.00 |
| Dec 31, 2014 | 179,000.00 |
| Sep 30, 2014 | 232,064.00 |
| Jun 30, 2014 | 193,140.00 |
| Dec 31, 2013 | 357,000.00 |